col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Just Medical Media, Ltd.

26 Results       Page 1

  original article Journal Date Title Authors All Authors
1 [GO] Drugs in Context 2023―Jun―26 Individuals at risk for severe COVID-19 in whom ritonavir-containing therapies are contraindicated or may lead to interactions with concomitant medications: a retrospective analysis of German health insurance claims data Christoph Lübbert, Igor Dykukha, Jann-Patrick Pelz, Helen Yearley, Wolfgang Junker, Nina Gruber, et al. (+4)
2 [GO] Drugs in Context 2023―Jun―07 Changes in nasal, pharyngeal and salivary secretory IgA levels in patients with COVID-19 and the possibility of correction of their secretion using combined intranasal and oral administration of a pharmaceutical containing antigens of opportunistic microorganisms Mikhail Kostinov, Oksana Svitich, Alexander Chuchalin, Natalya Abramova, Valery Osiptsov, Ekaterina Khromova, et al. (+8)
3 [GO] Drugs in Context 2023―Feb―15 A single-centre experience rolling out an antibiotic stewardship intervention prior to and during the SARS-CoV-2 pandemic 2019-2022 Zahra Kassamali Escobar, Todd Bouchard, Cameron Buck, Kamaldeep Sandhu, Chloe Bryson-Cahn
4 [GO] Drugs in Context 2023―Feb―06 COVID-19 therapy and vaccination: a clinical narrative review Siddharth Chinta, Miguel Rodriguez-Guerra, Mohammed Shaban, Neelanjana Pandey, Maria Jaquez-Duran, Timothy J Vittorio
5 [GO] Drugs in Context 2022―Jun―16 Addressing COVID-19 vaccine hesitancy George Kassianos, Joan Puig-Barberà, Hannah Dinse, Martin Teufel, Özlem Türeci, Shanti Pather
6 [GO] Drugs in Context 2022―Apr―08 Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome Steven H Abman, Nicholas R Fox, M Ibrahim Malik, Sneha S Kelkar, Shelby L Corman, Sanika Rege, et al. (+7)
7 [GO] Drugs in Context 2022―Mar―01 Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19 Sergey V Efimov, Natallia V Matsiyeuskaya, Olga V Boytsova, Luydmila Yu Akhieva, Elena V Kuntsevich, Anastasia A Troshina, et al. (+6)
8 [GO] Drugs in Context 2022―Jan―21 Dabigatran in patients with atrial fibrillation after COVID-19 hospitalization: an update of the ANIBAL* protocol Juan José Cerezo-Manchado, Olga Meca Birlanga, Luis García de Guadiana Romualdo, Ignacio Gil-Ortega, Antonio Martínez Francés, Teodoro Iturbe-Hernandez
9 [GO] Drugs in Context 2021―Dec―12 COVID-19-related adaptations to the implementation and evaluation of a clinic-based intervention designed to improve opioid safety Anna R Morgan, Michelle A Hendricks, Sanae El Ibrahimi, Sara E Hallvik, Brigit Hatch, Caitlin Dickinson, et al. (+2)
10 [GO] Drugs in Context 2021―Oct―05 Vitamins, supplements and COVID-19: a review of currently available evidence Lauren Speakman, Sarah Michienzi, Melissa Badowski
11 [GO] Drugs in Context 2021―Jun―23 Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study Sergey V Efimov, Natallia V Matsiyeuskaya, Olga V Boytsova, Lyudmila Yu Akhieva, Elena I Kvasova, Francisco Harrison, et al. (+5)
12 [GO] Drugs in Context 2021―Jun―08 Dermatologists’ attitude towards psoriasis treatment during the COVID-19 pandemic Tiago Torres, Marta Pereira, Maria João Paiva Lopes, Clarisse Rebelo, Pedro Andrade, Martinha Henrique, et al. (+7)
13 [GO] Drugs in Context 2021―May―24 The UK approach to COVID-19 vaccination: why was it so different? Peter MB English
14 [GO] Drugs in Context 2021―Mar―23 The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study Sergey V Efimov, Natallia V Matsiyeuskaya, Olga V Boytsova, Lyudmila Yu Akhieva, Elena I Kvasova, Francisco Harrison, et al. (+5)
15 [GO] Drugs in Context 2021―Feb―15 The race to a COVID-19 vaccine: opportunities and challenges in development and distribution Rodrigo M Burgos, Melissa E Badowski, Emily Drwiega, Samaneh Ghassemi, Nikki Griffith, Fischer Herald, et al. (+3)
16 [GO] Drugs in Context 2021―Jan―29 Current treatment in COVID-19 disease: a rapid review Miguel Rodriguez-Guerra, Preeti Jadhav, Timothy J Vittorio
17 [GO] Drugs in Context 2020―Sep―16 Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL* protocol Teodoro Iturbe-Hernandez, Luis García de Guadiana Romualdo, Ignacio Gil Ortega, Antonio Martínez Francés, Olga Meca Birlanga, Juan José Cerezo-Manchado
18 [GO] Drugs in Context 2020―Jun―29 Coronavirus disease 2019 (COVID-19): latest developments in potential treatments Kam Lun Hon, Karen Ka Yan Leung, Alexander KC Leung, Su Yun Qian, Vivian PY Chan, Patrick Ip, Ian CK Wong
19 [GO] Drugs in Context 2020―Jun―20 Can vitamins and/or supplements provide hope against coronavirus? Sarah M Michienzi, Melissa E Badowski
20 [GO] Drugs in Context 2020―Jun―10 Neurological features of COVID-19 and their treatment: a review Daniele Orsucci, Elena Caldarazzo Ienco, Gianpaolo Nocita, Alessandro Napolitano, Marco Vista
21 [GO] Drugs in Context 2020―May―23 A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic Matteo Bassetti, Paolo Pelosi, Chiara Robba, Antonio Vena, Daniele Roberto Giacobbe
22 [GO] Drugs in Context 2020―May―20 The journey of remdesivir: from Ebola to COVID-19 Joe Pardo, Ashutosh M Shukla, Gajapathiraju Chamarthi, Asmita Gupte
23 [GO] Drugs in Context 2020―May―17 Pharmacological treatment of COVID-19: lights and shadows Francesco Menzella, Mirella Biava, Chiara Barbieri, Francesco Livrieri, Nicola Facciolongo
24 [GO] Drugs in Context 2020―May―13 Psoriasis, biologic therapy, and the pandemic of the 21st century Miguel Nogueira, Ron Vender, Tiago Torres
25 [GO] Drugs in Context 2020―May―10 Facing the COVID-19 outbreak in children with cancer Antonio Ruggiero, Alberto Romano, Giorgio Attinà
26 [GO] Drugs in Context 2020―Apr―27 Chloroquine and hydroxychloroquine in the context of COVID-19 Ashutosh M Shukla, Lennox K Archibald, Aparna Wagle Shukla, Hiren J Mehta, Kartikeya Cherabuddi

26 Results       Page 1


Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.009 sec